Attached files
| file | filename |
|---|---|
| 10-Q - GENEREX BIOTECHNOLOGY CORP | v188009_10q.htm |
| EX-10.5 - GENEREX BIOTECHNOLOGY CORP | v188009_ex10-5.htm |
| EX-31.1 - GENEREX BIOTECHNOLOGY CORP | v188009_ex31-1.htm |
| EX-31.2 - GENEREX BIOTECHNOLOGY CORP | v188009_ex31-2.htm |
| EX-10.6 - GENEREX BIOTECHNOLOGY CORP | v188009_ex10-6.htm |
| EX-10.1 - GENEREX BIOTECHNOLOGY CORP | v188009_ex10-1.htm |
| EX-10.2 - GENEREX BIOTECHNOLOGY CORP | v188009_ex10-2.htm |
| EX-10.3 - GENEREX BIOTECHNOLOGY CORP | v188009_ex10-3.htm |
| EX-10.4 - GENEREX BIOTECHNOLOGY CORP | v188009_ex10-4.htm |
| EX-10.7 - GENEREX BIOTECHNOLOGY CORP | v188009_ex10-7.htm |
Exhibit
32
CERTIFICATIONS
Pursuant
to Section 906 of the Public Company Accounting Reform and Investor Protection
Act of 2002 (18 U.S.C. ss. 1350, as adopted), Anna E. Gluskin, Chief Executive
Officer and President of Generex Biotechnology Corporation (the "Company"), and
Rose C. Perri, Chief Financial Officer of the Company, each hereby certifies
that, to the best of her knowledge:
1. The
Company's Quarterly Report on Form 10-Q for the period ended April 30, 2010 to
which this Certification is attached as Exhibit 32 (the "Report") fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934, as amended; and
2. The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company at the end of
the period covered by the Report.
|
DATE:
June 11, 2010
|
By: /s/ Anna E. Gluskin
|
|
|
Anna
E. Gluskin, Chief Executive Officer
|
||
|
(Principal
Executive Officer)
|
||
|
DATE:
June 11, 2010
|
By: /s/ Rose C. Perri
|
|
|
Rose
C. Perri, Chief Financial Officer
|
||
|
(Principal
Financial and Accounting
Officer)
|